ProFound AI® for DBT

FDA & CE | Breast | DBT | Amplifier Partner

Description of use

ProFound AI® for DBT is a concurrent-read, cancer detection and workflow solution that rapidly analyzes each DBT slice, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy. The software is intended to assist radiologists in identifying soft tissue densities and calcifications that may be confirmed or dismissed by the radiologist.

Built on the latest deep-learning AI technology, ProFound AI® assists radiologists in addressing key challenges of reading 2D and 3D mammography.

Impact on radiologist performance when reading DBT with vs without ProFound AI®:

  • 8.0% increase in sensitivity
  • 6.9% increase in specificity
  • 7.2% decrease in recall rate
  • 52.7% decrease in reading time

Regulatory Clearance:

  • FDA Cleared, CE Mark Approved, Health Canada Licensed

The application content is provided by the respective AI vendors.